Were Analysts Bearish Inovalon Holdings, Inc. (NASDAQ:INOV) This Week?

March 20, 2018 - By Stephen Andrade

 Were Analysts Bearish Inovalon Holdings, Inc. (NASDAQ:INOV) This Week?

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Coverage

Among 11 analysts covering Inovalon Holdings Inc (NASDAQ:INOV), 1 have Buy rating, 3 Sell and 7 Hold. Therefore 9% are positive. Inovalon Holdings Inc had 25 analyst reports since August 6, 2015 according to SRatingsIntel. Citigroup maintained the shares of INOV in report on Thursday, August 4 with “Neutral” rating. The firm earned “Underweight” rating on Wednesday, March 30 by Morgan Stanley. The stock of Inovalon Holdings, Inc. (NASDAQ:INOV) earned “Market Perform” rating by Wells Fargo on Tuesday, December 13. As per Tuesday, March 29, the company rating was initiated by Pacific Crest. The rating was initiated by First Analysis on Tuesday, October 25 with “Equal-Weight”. The rating was downgraded by William Blair on Thursday, August 4 to “Market Perform”. On Monday, October 16 the stock rating was maintained by KeyBanc Capital Markets with “Hold”. Goldman Sachs downgraded it to “Neutral” rating and $17 target in Thursday, August 4 report. The rating was maintained by Piper Jaffray with “Sell” on Wednesday, February 21. KeyBanc Capital Markets maintained Inovalon Holdings, Inc. (NASDAQ:INOV) on Tuesday, September 12 with “Hold” rating. Below is a list of Inovalon Holdings, Inc. (NASDAQ:INOV) latest ratings and price target changes.

14/03/2018 Broker: Morgan Stanley Old Rating: Equal-Weight New Rating: Underweight Old Target: $14 Downgrade
21/02/2018 Broker: Piper Jaffray Rating: Sell New Target: $8.0 Maintain
21/02/2018 Broker: Wells Fargo Old Rating: Market Perform New Rating: Market Perform Old Target: $16 New Target: $14 Maintain
16/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
13/10/2017 Broker: Robert W. Baird Rating: Hold New Target: $13.0 Maintain

The stock decreased 0.69% or $0.075 during the last trading session, reaching $10.725. About 28,441 shares traded. Inovalon Holdings, Inc. (NASDAQ:INOV) has declined 28.38% since March 20, 2017 and is downtrending. It has underperformed by 45.08% the S&P500.

Inovalon Holdings, Inc., a technology company, provides cloud platforms empowering a data-driven transformation from volume to value models throughout the healthcare industry. The company has market cap of $1.55 billion. The firm through, large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, enables the assessment and improvement of clinical and quality outcomes, and financial performance across the healthcare ecosystem. It has a 45.06 P/E ratio. It serves health plans and well-known provider organizations, as well as pharmaceutical, medical device, and diagnostics companies.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.